Your Guide to Safer Medication Use

Semaglutide

GLP-1 receptor agonist

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management. It enhances insulin secretion, slows gastric emptying, and reduces appetite through central nervous system pathways.

Tirzepatide

Dual GIP/GLP-1 receptor agonist

Tirzepatide is a once-weekly injectable peptide that activates both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound).

Tesofensine

Triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine)

Tesofensine is a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine that has been investigated in clinical trials as an appetite suppressant for obesity. It is NOT approved by the FDA and is not an established medical treatment in the United States.

AOD 9604

Human growth hormone fragment peptide

AOD 9604 is a synthetic peptide derived from the C-terminal region (amino acids 176–191) of human growth hormone. It has been investigated preclinically and in early clinical trials for its potential effects on fat metabolism. It is NOT approved by the FDA for any indication.

5-Amino-1MQ

NNMT (nicotinamide N-methyltransferase) inhibitor — research compound

5-Amino-1MQ is a laboratory research compound that inhibits nicotinamide N-methyltransferase (NNMT). Preclinical studies have examined NNMT-related metabolic pathways, but there is no established human clinical evidence and it is not approved by the FDA.

Tesamorelin

Synthetic growth hormone-releasing hormone (GHRH) analogue

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce growth hormone. It is FDA-approved for the reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. It is used off-label in other contexts.

SLU-PP-332

Estrogen-related receptor (ERRα/γ) agonist — research compound

SLU-PP-332 is a synthetic small molecule that selectively activates estrogen-related receptors (ERRα and ERRγ), which regulate mitochondrial biogenesis and energy metabolism. It has been proposed as an "exercise mimetic" in preclinical studies. It has no human clinical data.

L-Carnitine

Amino acid derivative / cellular energy cofactor

L-Carnitine (levocarnitine) is an amino acid derivative essential for fatty acid transport into mitochondria for energy production. FDA-approved injectable levocarnitine exists for carnitine deficiency in dialysis patients. Injectable L-carnitine for performance enhancement is a compounded off-label use.

Loco/Polli (Morph Weight Loss Blend)

Proprietary oral compound blend — multiple ingredients

Loco/Polli and related Morph-branded capsule formulations are proprietary oral blends whose exact ingredients and evidence base are not publicly disclosed in full. They are not standardized or FDA-approved finished drug products.

LipoMorph (Topical Fat-Reduction Cream)

Proprietary compounded topical cream — multiple ingredients

LipoMorph is a proprietary compounded topical cream formulated to target subcutaneous fat and reduce the appearance of cellulite and stretch marks. The specific active ingredients are compounding-pharmacy-specific. It is not an FDA-approved drug product and its efficacy has not been evaluated through FDA review.

INFERNO Stack

Proprietary multi-peptide injection blend

INFERNO is a proprietary injectable blend of AOD-9604, CJC-1295, Ipamorelin, and MOTS-C. None of the individual components are FDA-approved for the promoted uses, and the combination has not been studied in human trials.

Kali Stack

Proprietary multi-compound injection blend

Kali is a proprietary compounded injectable blend combining BPC-157, MOTS-C, 5-Amino-1MQ, and Tesamorelin. Components span FDA-approved (tesamorelin for specific HIV-related indication), investigational (BPC-157, MOTS-C, 5-Amino-1MQ), and unapproved uses. The combination is not FDA-approved.

Selene Stack

Proprietary two-compound injection blend

The Selene Stack is a proprietary compounded injectable blend of GHK-Cu and Tesamorelin. Tesamorelin has its own FDA-approved indication (HIV-related lipodystrophy) but is used off-label in this context. GHK-Cu as an injectable is investigational. The combination is not FDA-approved.

Linc (Amylin Analogue)

Long-acting amylin analogue — investigational

Linc is described as a long-acting amylin analogue designed to suppress appetite, slow gastric emptying, and reduce food intake. Pramlintide (Symlin) is an FDA-approved amylin analogue for diabetes. Linc as a long-acting variant is investigational and not FDA-approved.

Diabetes

3 profiles

Semaglutide

GLP-1 receptor agonist

Tirzepatide

Dual GIP/GLP-1 receptor agonist

Linc (Amylin Analogue)

Long-acting amylin analogue — investigational

Cardiovascular

1 profiles

Semaglutide

GLP-1 receptor agonist

Hormones

18 profiles

Tesamorelin

Synthetic growth hormone-releasing hormone (GHRH) analogue

CJC-1295 / Ipamorelin

GHRH analogue + GHSR agonist combination — research compound

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue with a prolonged half-life. Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist. The combination is used to stimulate pulsatile growth hormone release. Neither is FDA-approved for general health or performance use.

Sermorelin / Ipamorelin

GHRH analogue + GHSR agonist combination — compounded

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that was previously FDA-approved (as Geref) but is currently only available as a compounded preparation in the US. Ipamorelin is a selective GHSR agonist. The combination is used in compounding to stimulate growth hormone secretion.

MK-677 (Ibutamoren)

Oral ghrelin receptor agonist / growth hormone secretagogue — research compound

MK-677 (ibutamoren) is an orally active, non-peptide ghrelin receptor agonist that stimulates the pituitary to release growth hormone. It has been studied in clinical trials for muscle wasting and growth hormone deficiency but has NOT received FDA approval for any indication.

Hexarelin

Growth hormone secretagogue (GHSR agonist) — research compound

Hexarelin is a synthetic hexapeptide that acts on the growth hormone secretagogue receptor (GHSR/ghrelin receptor) to stimulate pituitary growth hormone release. It has been studied in limited human trials but is NOT approved by the FDA for any indication.

Kisspeptin

Hypothalamic neuropeptide / GnRH secretagogue — research compound

Kisspeptin is a naturally occurring neuropeptide produced in the hypothalamus that plays a central role in regulating the hormonal reproductive axis (HPG axis) by stimulating GnRH release. It has been studied in clinical trials for fertility and hypoactive sexual desire. It is not FDA-approved for general use.

Testosterone Cypionate

Androgen (Schedule III controlled substance)

Testosterone cypionate is an FDA-approved injectable androgen ester used for testosterone replacement therapy (TRT) in males with documented hypogonadism. It is classified as a DEA Schedule III controlled substance. Testosterone is also used off-label in gender-affirming care under specialist supervision.

Testosterone Undecanoate (Kyzatrex)

Oral androgen (testosterone undecanoate, Schedule III controlled substance)

Testosterone undecanoate (Kyzatrex) is an FDA-approved oral testosterone ester for male hypogonadism. Unlike injectable testosterone esters, it is taken by mouth twice daily with food. It is a DEA Schedule III controlled substance. Jatenzo is another FDA-approved oral testosterone undecanoate product.

Anastrozole

Non-steroidal aromatase inhibitor

Anastrozole is an FDA-approved aromatase inhibitor that blocks the conversion of androgens to estrogen. It is approved for breast cancer treatment in postmenopausal women. It is also used off-label in males on testosterone replacement therapy to manage estrogen elevation.

HCG (Human Chorionic Gonadotropin)

Gonadotropin hormone

Human chorionic gonadotropin (HCG) is an FDA-approved gonadotropin hormone used in reproductive medicine and to treat hypogonadism in males. It acts on the same receptor as luteinizing hormone (LH) to stimulate testosterone production in the testes and support spermatogenesis.

Gonadorelin

Synthetic gonadotropin-releasing hormone (GnRH)

Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH) that stimulates the pituitary to release LH and FSH. FDA-approved formulations have been used for fertility diagnostics and primary hypothalamic amenorrhea. Compounded gonadorelin is used off-label in male TRT to preserve testicular function.

Enclomiphene

Selective estrogen receptor modulator (SERM) — estrogen antagonist

Enclomiphene is the trans-isomer of clomiphene citrate. It acts as an estrogen receptor antagonist at the hypothalamic-pituitary level, blocking estrogen's negative feedback and thereby increasing LH and FSH output to stimulate testicular testosterone production. It is not independently FDA-approved for male hypogonadism.

Bi-Estriol (Biest)

Bioidentical estrogen combination — compounded

Bi-estriol (or "Biest") is a compounded bioidentical estrogen preparation containing estradiol and estriol in varying ratios. It is used in compounded hormone replacement therapy. Neither estriol alone nor the Biest combination is FDA-approved as a standardized drug product.

Estradiol (Injectable)

Bioidentical estrogen — FDA-approved injectable

Estradiol is the primary endogenous estrogen and is FDA-approved in multiple forms including injectable formulations. Compounded injectable estradiol (as hemihydrate, cypionate, or valerate) is also available through licensed pharmacies for menopausal hormone therapy or transgender feminizing hormone therapy.

Progesterone

Bioidentical progestogen — FDA-approved

Progesterone is an FDA-approved naturally occurring hormone used in hormone replacement therapy to protect the uterine lining (endometrium) in women with an intact uterus who are receiving estrogen therapy, and for secondary amenorrhea.

Tamoxifen

Selective estrogen receptor modulator (SERM)

Tamoxifen is an FDA-approved SERM used for treatment and risk reduction of hormone receptor-positive breast cancer. In males, it is used off-label to prevent or treat gynecomastia and to restore hypothalamic-pituitary-gonadal axis function after anabolic steroid use (post-cycle therapy — not an FDA-approved indication).

Exemestane

Irreversible steroidal aromatase inhibitor

Exemestane is an FDA-approved, irreversible steroidal aromatase inhibitor that permanently inactivates aromatase, reducing estrogen synthesis. It is approved for breast cancer treatment in postmenopausal women.

EMPRESS Stack

Proprietary multi-peptide injection blend

The EMPRESS Stack is a proprietary compounded injectable blend containing MOTS-C, BPC-157, GHK-Cu, and Kisspeptin. Each component is individually investigational or a research compound. The combined formulation is not FDA-approved, and interactions between components have not been studied in human clinical trials.

Recovery & Performance

21 profiles

BPC-157

Gastric pentadecapeptide — research compound

BPC-157 is a synthetic pentadecapeptide studied in laboratory and animal models for possible effects on tissue and gastrointestinal pathways. It is not approved by the FDA for any human indication.

TB-500

Synthetic thymosin beta-4 peptide fragment — research compound

TB-500 is a synthetic peptide fragment of thymosin beta-4, a naturally occurring protein involved in actin regulation and cell migration. It has been studied in preclinical models for wound healing and tissue repair. It is NOT approved by the FDA for any human use.

Thymosin Beta-4

Naturally occurring actin-sequestering peptide

Thymosin beta-4 is a naturally occurring 43-amino-acid peptide involved in actin regulation, cell migration, and tissue repair. It has been studied in clinical trials for corneal healing and cardiac tissue repair. Systemic use outside approved indications is investigational.

IGF-1 LR3

Recombinant IGF-1 analogue — research compound

IGF-1 LR3 is a recombinant analogue of insulin-like growth factor-1 with an extended half-life due to an arginine substitution and N-terminal extension. It has been used in research settings. It is NOT approved by the FDA for bodybuilding or general health use.

CJC-1295 / Ipamorelin

GHRH analogue + GHSR agonist combination — research compound

MOTS-C

Mitochondria-derived peptide — research compound

MOTS-C is a 16-amino-acid peptide encoded within the 12S rRNA gene of mitochondrial DNA. It has been studied in preclinical models for its role in energy metabolism via AMPK activation. It is NOT approved by the FDA and its human effects are not established.

Sermorelin / Ipamorelin

GHRH analogue + GHSR agonist combination — compounded

MK-677 (Ibutamoren)

Oral ghrelin receptor agonist / growth hormone secretagogue — research compound

Hexarelin

Growth hormone secretagogue (GHSR agonist) — research compound

Nandrolone

Anabolic-androgenic steroid (Schedule III controlled substance)

Nandrolone decanoate (Deca-Durabolin) is an anabolic-androgenic steroid derived from testosterone. It has been FDA-approved for anemia of chronic renal failure and, historically, for other wasting conditions. It is a DEA Schedule III controlled substance.

Oxandrolone

Anabolic-androgenic steroid (Schedule III controlled substance)

Oxandrolone is an FDA-approved anabolic steroid used for weight gain after surgery, trauma, or chronic infection, and for bone pain associated with osteoporosis. It is a DEA Schedule III controlled substance.

SLU-PP-332

Estrogen-related receptor (ERRα/γ) agonist — research compound

SS-31 (Elamipretide)

Mitochondria-targeting tetrapeptide — research compound

SS-31 (elamipretide) is a synthetic cell-permeable tetrapeptide that targets the inner mitochondrial membrane, reducing oxidative stress and improving mitochondrial function. It has been studied in clinical trials for heart failure and Barth syndrome. It has not received FDA approval.

Ostarine (MK-2866)

Selective androgen receptor modulator (SARM) — investigational

Ostarine (enobosarm) is an investigational SARM that binds androgen receptors selectively in muscle and bone tissue. It has been in clinical trials for muscle wasting (cancer cachexia) but has NOT received FDA approval. SARMs as a class are not FDA-approved as drugs and are not legal dietary supplements.

GW501516 (Cardarine)

PPARδ agonist — abandoned research compound

GW501516 (Cardarine) is a PPARδ agonist that was investigated for dyslipidemia and metabolic disease. Development was ABANDONED by GlaxoSmithKline after preclinical studies showed rapid cancer development in multiple organ systems at therapeutic doses. It is NOT approved by the FDA and is considered hazardous.

L-Carnitine

Amino acid derivative / cellular energy cofactor

EMPRESS Stack

Proprietary multi-peptide injection blend

INFERNO Stack

Proprietary multi-peptide injection blend

Kali Stack

Proprietary multi-compound injection blend

Samson and Delilah Stack

Proprietary multi-peptide injection blend

The Samson and Delilah Blend is a proprietary injectable combination of GHK-Cu, CJC-1295, Ipamorelin, and TB-500. The combination has not been studied in human trials and is not FDA-approved.

KLOW Stack

Proprietary multi-peptide injection blend

KLOW is a proprietary injectable blend of BPC-157, TB-500, GHK-Cu, and KPV. The combination has not been studied in human trials and is not FDA-approved.

Gut Health

4 profiles

BPC-157

Gastric pentadecapeptide — research compound

BPC-157 is a synthetic pentadecapeptide studied in laboratory and animal models for possible effects on tissue and gastrointestinal pathways. It is not approved by the FDA for any human indication.

Larazotide

Tight junction peptide modulator — research compound

Larazotide acetate is a synthetic 8-amino-acid peptide that acts as a tight junction regulator, reducing intestinal permeability ("leaky gut"). It has been studied in Phase 2 and Phase 3 clinical trials for celiac disease but has not received FDA approval.

KPV

Alpha-MSH C-terminal tripeptide — research compound

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone (α-MSH). It has potent anti-inflammatory properties in preclinical models and has been studied for inflammatory bowel disease and skin inflammatory conditions. It is NOT FDA-approved.

Naltrexone (Low-Dose)

Opioid receptor antagonist

Naltrexone is an FDA-approved opioid receptor antagonist used for opioid use disorder and alcohol use disorder. At standard doses it blocks opioid receptors. At sub-therapeutic "low doses" (LDN, 1.5–4.5 mg) it is used off-label for chronic pain, fibromyalgia, Crohn's disease, and immune modulation — an area of active research.

Sleep & Cognitive Function

10 profiles

DSIP

Neuropeptide — research compound

Delta sleep-inducing peptide (DSIP) is a naturally occurring neuropeptide first isolated from rabbit thalamus. It has been studied in limited clinical research for sleep modulation, but is NOT approved by the FDA and its mechanisms in humans are not well characterized.

Epithalon

Synthetic tetrapeptide — research compound

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide studied mainly in preclinical research for possible effects on telomere-related cellular pathways. It is not approved by the FDA, and its safety and efficacy in humans are not established.

NAD+

Coenzyme / cellular energy metabolite

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential to redox reactions and cellular energy metabolism. Injectable and IV formulations are used in compounded preparations for potential anti-aging and energy support, though FDA-approved indications for injectable NAD+ are limited.

Dihexa

Angiotensin IV analogue — research compound

Dihexa is a synthetic angiotensin IV analogue studied in animal models for possible effects on neurological signaling pathways. It is not approved by the FDA, has not completed human clinical trials, and its safety in humans is unknown.

Cerebrolysin

Neuropeptide mixture (porcine brain origin) — research compound

Cerebrolysin is a mixture of peptides and amino acids derived from porcine (pig) brain tissue. It has been studied in Eastern European and Chinese clinical trials for stroke recovery, traumatic brain injury, and dementia. It is NOT approved by the FDA in the United States.

PE-22-28

Synthetic neuropeptide (TREK-1 inhibitor) — research compound

PE-22-28 is a synthetic 7-amino-acid peptide analogue of spadin, a naturally occurring peptide that inhibits the TREK-1 (tandem-pore-domain) potassium channel. TREK-1 inhibition has been proposed as a mechanism for antidepressant effects. PE-22-28 is a research compound with no human clinical trials.

Selank

Synthetic anxiolytic heptapeptide — research compound

Selank is a synthetic heptapeptide analogue of tuftsin developed in Russia. It has been studied in Russian clinical trials for anxiety and cognitive enhancement. It has anxiolytic effects without sedation in limited studies. It is NOT FDA-approved in the United States.

Semax

Synthetic ACTH/MSH analogue — research compound

Semax is a synthetic heptapeptide analogue of the ACTH 4-10 fragment with additional Pro-Gly-Pro extension. It has been studied in Russia for cognitive enhancement, neuroprotection, and BDNF stimulation. It is NOT FDA-approved in the United States.

Pinealon / PE 22-28 / Selank Blend

Proprietary multi-peptide intranasal blend

A proprietary compounded intranasal spray containing Pinealon (a synthetic tripeptide with purported antioxidant and neuroprotective properties), PE-22-28 (TREK-1 inhibitor research compound), and Selank (synthetic anxiolytic peptide). All three components are research compounds without FDA approval.

Methylene Blue

Phenothiazine dye / oxidation-reduction agent

Methylene blue is a synthetic compound with diverse pharmacological actions. It is FDA-approved for methemoglobinemia. It has been investigated off-label for anti-aging, cognitive support, and as a mitochondrial electron carrier. Low-dose methylene blue is available in compounded preparations for off-label uses.

Anti-Aging & Longevity

16 profiles

Epithalon

Synthetic tetrapeptide — research compound

NAD+

Coenzyme / cellular energy metabolite

MOTS-C

Mitochondria-derived peptide — research compound

SS-31 (Elamipretide)

Mitochondria-targeting tetrapeptide — research compound

Thymulin

Thymic zinc-dependent nonapeptide — research compound

Thymulin is a naturally occurring zinc-dependent nonapeptide produced by the thymus gland. It plays a role in T-cell differentiation and immune regulation. It has also been investigated for hair follicle support and wound healing. It is not FDA-approved for any indication.

GHK-Cu (Copper Peptide)

Copper-binding tripeptide — supplement / compounded cosmeceutical

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide found in human plasma. It has been studied extensively for wound healing, collagen stimulation, and anti-aging skin effects. It is available in topical cosmeceutical products and compounded injectable preparations. No injectable form is FDA-approved.

Folic Acid (Injectable)

B-vitamin (folate) — injectable supplement

Folic acid (folate, vitamin B9) is an essential B vitamin required for DNA synthesis, cell division, and neural tube development. Injectable folic acid is FDA-approved for folate deficiency states. Injectable use for general wellness or cognitive support is a supplemental off-label use.

Methyltetrahydrofolate (5-MTHF)

Active folate metabolite — supplement / prescription medical food

Methyltetrahydrofolate (5-MTHF, L-methylfolate) is the biologically active, methylated form of folate that is directly usable by cells without enzymatic conversion. It is available as a dietary supplement and, in some formulations, as a prescription medical food (e.g., Deplin) for individuals with MTHFR gene variants that impair folate metabolism.

Ascorbic Acid (Vitamin C Injectable)

Water-soluble vitamin / antioxidant — injectable supplement

Ascorbic acid (vitamin C) is an essential water-soluble vitamin involved in collagen synthesis, iron absorption, and antioxidant defense. Injectable vitamin C is FDA-approved for specific deficiency states; high-dose IV use is investigational for certain oncological adjunct protocols.

morph Skin Sciences

Proprietary compounded skincare / cosmeceutical blend

morph Skin Sciences encompasses a range of compounded peptide-based skincare products including a Peptide Renewal Serum (GHK-Cu + vitamin A derivative) and a Rejuvenation Facial Cream (hyaluronic acid + GHK-Cu), with an optional tretinoin-containing variant. Individual products may contain FDA-approved ingredients (tretinoin) or supplement-grade actives (GHK-Cu). The proprietary blends themselves are not FDA-approved as standardized drug products.

EMPRESS Stack

Proprietary multi-peptide injection blend

Samson and Delilah Stack

Proprietary multi-peptide injection blend

The Samson and Delilah Blend is a proprietary injectable combination of GHK-Cu, CJC-1295, Ipamorelin, and TB-500. The combination has not been studied in human trials and is not FDA-approved.

Selene Stack

Proprietary two-compound injection blend

KLOW Stack

Proprietary multi-peptide injection blend

KLOW is a proprietary injectable blend of BPC-157, TB-500, GHK-Cu, and KPV. The combination has not been studied in human trials and is not FDA-approved.

GHK-Cu / Epithalon Blend

Proprietary two-peptide injection blend

A compounded injectable blend of GHK-Cu (copper-binding tripeptide) and Epithalon (synthetic tetrapeptide). Both components are research/investigational compounds; the blend is not FDA-approved.

Methylene Blue

Phenothiazine dye / oxidation-reduction agent

Sexual Health

8 profiles

Bremelanotide (PT-141)

Melanocortin receptor agonist

Bremelanotide (PT-141) is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts on melanocortin receptors (MC1R, MC3R, MC4R) in the central nervous system to modulate sexual desire. It is FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women.

Melanotan II

Non-selective melanocortin receptor agonist — research compound

Melanotan II is a synthetic alpha-MSH analogue that activates several melanocortin receptors. It is promoted online for tanning and other effects, but it is not approved by the FDA and carries significant safety concerns.

Tadalafil

Phosphodiesterase type 5 (PDE5) inhibitor

Tadalafil is an FDA-approved PDE5 inhibitor that relaxes smooth muscle in blood vessel walls, increasing blood flow. It is approved for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension.

Oxytocin

Neurohypophysial hormone / neuropeptide

Oxytocin is a naturally occurring neuropeptide produced in the hypothalamus. FDA-approved forms are used for labor induction and postpartum hemorrhage. Compounded intranasal and injectable oxytocin are used off-label for mood, bonding, and sexual function support; these uses are not FDA-approved.

Kisspeptin

Hypothalamic neuropeptide / GnRH secretagogue — research compound

Love & Happiness Stack

Proprietary sexual wellness injection blend

The Love & Happiness Stack is a proprietary compounded injectable blend of oxytocin and bremelanotide (PT-141). Bremelanotide is FDA-approved for premenopausal women with HSDD; oxytocin is FDA-approved only for obstetric use. The combined product is not FDA-approved.

Bremelanotide / Oxytocin / Tadalafil Blend

Proprietary sexual wellness sublingual combination

A proprietary compounded sublingual troche combining bremelanotide (PT-141, FDA-approved for HSDD in premenopausal women), oxytocin (FDA-approved for obstetric use), and tadalafil (FDA-approved PDE5 inhibitor for ED/BPH). Each component has its own FDA-approved indication, but the combination product is not FDA-approved.

Tri-Mix (Trimix)

Compounded intracavernosal vasoactive combination

Trimix is a compounded intracavernosal injection containing three vasoactive agents: alprostadil (a prostaglandin, FDA-approved as Caverject), papaverine (a vasodilator), and phentolamine (an alpha-adrenergic blocker). The combination product is compounded and not FDA-approved as a fixed combination, but it is a well-established clinical practice for erectile dysfunction refractory to oral PDE5 inhibitors.

Men's Health

11 profiles

Tadalafil

Phosphodiesterase type 5 (PDE5) inhibitor

Testosterone Cypionate

Androgen (Schedule III controlled substance)

Testosterone Undecanoate (Kyzatrex)

Oral androgen (testosterone undecanoate, Schedule III controlled substance)

Anastrozole

Non-steroidal aromatase inhibitor

HCG (Human Chorionic Gonadotropin)

Gonadotropin hormone

Gonadorelin

Synthetic gonadotropin-releasing hormone (GnRH)

Enclomiphene

Selective estrogen receptor modulator (SERM) — estrogen antagonist

Nandrolone

Anabolic-androgenic steroid (Schedule III controlled substance)

Oxandrolone

Anabolic-androgenic steroid (Schedule III controlled substance)

Tamoxifen

Selective estrogen receptor modulator (SERM)

Tri-Mix (Trimix)

Compounded intracavernosal vasoactive combination

Mental Wellness

7 profiles

Oxytocin

Neurohypophysial hormone / neuropeptide

PE-22-28

Synthetic neuropeptide (TREK-1 inhibitor) — research compound

Naltrexone (Low-Dose)

Opioid receptor antagonist

Selank

Synthetic anxiolytic heptapeptide — research compound

Semax

Synthetic ACTH/MSH analogue — research compound

Methyltetrahydrofolate (5-MTHF)

Active folate metabolite — supplement / prescription medical food

Pinealon / PE 22-28 / Selank Blend

Proprietary multi-peptide intranasal blend

Oncology (Informational)

4 profiles

Anastrozole

Non-steroidal aromatase inhibitor

Tamoxifen

Selective estrogen receptor modulator (SERM)

Exemestane

Irreversible steroidal aromatase inhibitor

Fenbendazole

Benzimidazole anthelmintic (anti-parasitic)

Fenbendazole is a veterinary antiparasitic drug that is not approved for human use in the United States. Laboratory and animal studies do not establish that it is safe or effective as a cancer treatment in humans.

Fertility

3 profiles

HCG (Human Chorionic Gonadotropin)

Gonadotropin hormone

Gonadorelin

Synthetic gonadotropin-releasing hormone (GnRH)

Enclomiphene

Selective estrogen receptor modulator (SERM) — estrogen antagonist

Women's Health

4 profiles

Bi-Estriol (Biest)

Bioidentical estrogen combination — compounded

Estradiol (Injectable)

Bioidentical estrogen — FDA-approved injectable

Progesterone

Bioidentical progestogen — FDA-approved

Folic Acid (Injectable)

B-vitamin (folate) — injectable supplement

Thyroid

2 profiles

Liothyronine (T3)

Synthetic thyroid hormone (T3)

Liothyronine is a synthetic form of triiodothyronine (T3), the biologically active thyroid hormone. It is FDA-approved for hypothyroidism and as a pituitary TSH suppression agent in thyroid cancer management.

Thyroid Oral Capsules (T3/T4 Combination)

Combined synthetic or desiccated thyroid hormone (T3 + T4)

Compounded T3/T4 combination thyroid capsules provide both the active thyroid hormone T3 (liothyronine) and the prohormone T4 (levothyroxine) in a single preparation. Natural desiccated thyroid (NDT) products like NP Thyroid and Armour Thyroid are FDA-approved; custom-ratio compounded preparations are not standardized or FDA-approved.

Immune Support

5 profiles

Thymosin Alpha-1

Immunomodulatory peptide

Thymosin alpha-1 (thymalfasin, brand: Zadaxin) is a synthetic 28-amino-acid peptide that modulates immune function by stimulating T-cell maturation and natural killer cell activity. It is approved for hepatitis B and C in some countries outside the US. It is not FDA-approved in the United States for standard indications.

Thymulin

Thymic zinc-dependent nonapeptide — research compound

LL-37

Human cathelicidin antimicrobial peptide — research compound

LL-37 is the only known human cathelicidin, a 37-amino-acid cationic antimicrobial peptide derived from hCAP-18 with broad-spectrum antimicrobial activity and immunomodulatory functions. It is under investigation for wound healing and anti-infective applications. It is NOT FDA-approved.

KPV

Alpha-MSH C-terminal tripeptide — research compound

Ascorbic Acid (Vitamin C Injectable)

Water-soluble vitamin / antioxidant — injectable supplement

Skin & Hair

6 profiles

Thymulin

Thymic zinc-dependent nonapeptide — research compound

GHK-Cu (Copper Peptide)

Copper-binding tripeptide — supplement / compounded cosmeceutical

LipoMorph (Topical Fat-Reduction Cream)

Proprietary compounded topical cream — multiple ingredients

morpHair Products

Proprietary compounded topical hair treatment

morpHair Products are proprietary compounded topical formulations designed to stimulate hair growth and increase hair follicle number and thickness. Specific ingredients vary by formulation and may include minoxidil, peptides, or other actives. These are not FDA-approved standardized drug products.

morph Skin Sciences

Proprietary compounded skincare / cosmeceutical blend

GHK-Cu / Epithalon Blend

Proprietary two-peptide injection blend

A compounded injectable blend of GHK-Cu (copper-binding tripeptide) and Epithalon (synthetic tetrapeptide). Both components are research/investigational compounds; the blend is not FDA-approved.

Addiction & Substance Use

1 profiles